相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Combined cytotoxic and anti-invasive properties of redox-active nanoparticles in tumor-stroma interactions
Lirija Alili et al.
BIOMATERIALS (2011)
Bladder perforation in a patient with recurrent epithelial ovarian cancer after treatment with bevacizumab
Nisha Bansal et al.
GYNECOLOGIC ONCOLOGY (2011)
Overview of anti-angiogenic agents in development for ovarian cancer
Robert A. Burger
GYNECOLOGIC ONCOLOGY (2011)
The protective effects of cerium oxide nanoparticles against hepatic oxidative damage induced by monocrotaline
Kamal A. Amin et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2011)
Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner
R. Rattan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Metformin Suppresses Ovarian Cancer Growth and Metastasis with Enhancement of Cisplatin Cytotoxicity In Vivo
Ramandeep Rattan et al.
NEOPLASIA (2011)
From Nanotechnology to Nanomedicine: Applications to Cancer Research
R. Seigneuric et al.
CURRENT MOLECULAR MEDICINE (2010)
Vascular endothelial growth factor gene polymorphisms and ovarian cancer survival
Felicity Lose et al.
GYNECOLOGIC ONCOLOGY (2010)
Bevacizumab toxicities and their management in ovarian cancer
Leslie M. Randall et al.
GYNECOLOGIC ONCOLOGY (2010)
Phase II Study of Carboplatin, Paclitaxel, and Bevacizumab With Maintenance Bevacizumab As First-Line Chemotherapy for Advanced Mullerian Tumors
Richard T. Penson et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Emerging nanomedicines for early cancer detection and improved treatment: Current perspective and future promise
Dhruba J. Bharali et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Brain Distribution and Toxicological Evaluation of a Systemically Delivered Engineered Nanoscale Ceria
Sarita S. Hardas et al.
TOXICOLOGICAL SCIENCES (2010)
Angiogenesis and ovarian cancer
Cesar Gomez-Raposo et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2009)
Antiangiogenic drugs in ovarian cancer
Maurie Markman
EXPERT OPINION ON PHARMACOTHERAPY (2009)
PEGylated Nanoceria as Radical Scavenger with Tunable Redox Chemistry
Ajay S. Karakoti et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy
Masuko Ushio-Fukai et al.
CANCER LETTERS (2008)
Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells
David W. Chan et al.
CARCINOGENESIS (2008)
Nanoceria as antioxidant: Synthesis and biomedical applications
A. S. Karakoti et al.
JOM (2008)
Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: A trial of the California, Chicago, and princess Margaret hospital phase II consortia
Agustin A. Garcia et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The role of AMPK in psychosine mediated effects on oligodendrocytes and astrocytes: Implication for Krabbe Disease
Shailendra Giri et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Direct synthesis of nanoceria in aqueous polyhydroxyl solutions
A. S. Karakoti et al.
JOURNAL OF PHYSICAL CHEMISTRY C (2007)
Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: A Gynecologic oncology group study
Robert A. Burger et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer
Stephen A. Cannistra et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor
Chang Xia et al.
CANCER RESEARCH (2007)
Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential
Swanand Patil et al.
BIOMATERIALS (2007)
Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons
Mainak Das et al.
BIOMATERIALS (2007)
Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1α expression through activation of AKT and P70S6K1 in human ovarian cancer cells
Ling-Zhi Liu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides
Junping Chen et al.
NATURE NANOTECHNOLOGY (2006)
Krabbe disease: psychosine-mediated activation of phospholipase A2 in oligodendrocyte cell death
S. Giri et al.
JOURNAL OF LIPID RESEARCH (2006)
HSulf-1 inhibits angiogenesis and tumorigenesis in vivo
Keishi Narita et al.
CANCER RESEARCH (2006)
Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage
RW Tarnuzzer et al.
NANO LETTERS (2005)
5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase
R Rattan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Size dependency variation in lattice parameter and valency states in nanocrystalline cerium oxide
S Deshpande et al.
APPLIED PHYSICS LETTERS (2005)
Clinical translation of angiogenesis inhibitors
R Kerbel et al.
NATURE REVIEWS CANCER (2002)
A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-γ and DNA synthesis in vascular endothelial cells
T Takahashi et al.
EMBO JOURNAL (2001)
Angiogenesis in cancer and other diseases
P Carmeliet et al.
NATURE (2000)